Inhibition of R5-tropic HIV type-1 replication in CD4+ natural killer T cells by γδ T lymphocytes

Immunology

Volumn 141, Issue 4, 2014, Pages 596-608

  Omi, Kyoko ^a   Shimizu, Masumi ^a   Watanabe, Eri ^a   Matsumura, Jiro ^a   Takaku, Chizuno ^a   Shinya, Eiji ^a   Takahashi, Hidemi ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

HIV 1 p24; R5 tropic HIV 1; Viral replication; T cells

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; RANTES;

ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CELL POPULATION; CELL STIMULATION; CELL SURFACE; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; GAMMA DELTA T LYMPHOCYTE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INNATE IMMUNITY; MACROPHAGE; NATURAL KILLER T CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; T CELL DEPLETION; TROPISM; VIRION; VIRUS INHIBITION; VIRUS REPLICATION;

CD4+ NATURAL KILLER T CELLS; CD8ΑΑ+ CELLS; HIV-1 P24; R5-TROPIC HIV-1; VIRAL REPLICATION; ΓΔ T CELLS;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CHEMOKINE CCL5; COCULTURE TECHNIQUES; GALACTOSYLCERAMIDES; HISTOCOMPATIBILITY ANTIGENS CLASS I; HIV-1; HUMANS; NATURAL KILLER T-CELLS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; RECEPTORS, CCR5; TIME FACTORS; VIRUS REPLICATION;

EID: 84895809695     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/imm.12221     Document Type: Article

References (37)

1. + T cell homeostasis and function in advanced HIV disease. Science 1997; 277:112-6.
2. + cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996; 381:667-73.
3. Oberlin E, Amara A, Bachelerie F et al. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 1996; 382:833-5.
4. Bleul CC, Farzan M, Choe H, Parolin C, Clark-Lewis I, Sodroski J, Springer TA. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 1996; 382:829-33.
5. Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, Berger EA. CC CKR5: a RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996; 272:1955-8.
6. Wu L, Gerard NP, Wyatt R et al. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature 1996; 384:179-83.
7. Ruibal-Ares BH, Belmonte L, Bare PC, Parodi CM, Massud I, de Bracco MM. HIV-1 infection and chemokine receptor modulation. Curr HIV Res 2004; 2:39-50.
8. Motsinger A, Haas DW, Stanic AK, Van Kaer L, Joyce S, Unutmaz D. CD1d-restricted human natural killer T cells are highly susceptible to human immunodeficiency virus 1 infection. J Exp Med 2002; 195:869-79.
9. Kawano T, Cui J, Koezuka Y et al. CD1d-restricted and TCR-mediated activation of vα14 NKT cells by glycosylceramides. Science 1997; 278:1626-9.
10. Fleuridor R, Wilson B, Hou R, Landay A, Kessler H, Al-Harthi L. CD1d-restricted natural killer T cells are potent targets for human immunodeficiency virus infection. Immunology 2003; 108:3-9.
11. + lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 1986; 234:1563-6.
12. + T cells. Immunol Today 1996; 17:217-24.
13. Mackewicz CE, Yang LC, Lifson JD, Levy JA. Non-cytolytic CD8 T-cell anti-HIV responses in primary HIV-1 infection. Lancet 1994; 344:1671-3.
14. Englund G, Theodore TS, Freed EO, Engelman A, Martin MA. Integration is required for productive infection of monocyte-derived macrophages by human immunodeficiency virus type 1. J Virol 1995; 69:3216-9.
15. + cytotoxic T lymphocytes by free antigenic peptide: a self-veto mechanism? J Exp Med 1996; 183:879-89.
16. Wehrly K, Chesebro B. p24 antigen capture assay for quantification of human immunodeficiency virus using readily available inexpensive reagents. Methods 1997; 12:288-93.
17. Chesebro B, Wehrly K, Nishio J, Perryman S. Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism. J Virol 1992; 66:6547-54.
18. Steimer KS, Puma JP, Power MD et al. Differential antibody responses of individuals infected with AIDS-associated retroviruses surveyed using the viral core antigen p25gag expressed in bacteria. Virology 1986; 150:283-90.
19. Borst J, van de Griend RJ, van Oostveen JW, Ang SL, Melief CJ, Seidman JG, Bolhuis RL. A T-cell receptor γ/CD3 complex found on cloned functional lymphocytes. Nature 1987; 325:683-8.
20. Brenner MB, McLean J, Scheft H, Riberdy J, Ang SL, Seidman JG, Devlin P, Krangel MS. Two forms of the T-cell receptor γ protein found on peripheral blood cytotoxic T lymphocytes. Nature 1987; 325:689-94.
21. Hayday AC. γδ cells: a right time and a right place for a conserved third way of protection. Annu Rev Immunol 2000; 18:975-1026.
22. Evans PS, Enders PJ, Yin C, Ruckwardt TJ, Malkovsky M, Pauza CD. In vitro stimulation with a non-peptidic alkylphosphate expands cells expressing Vγ2-Jγ1.2/Vδ2 T-cell receptors. Immunology 2001; 104:19-27.
23. Kunzmann V, Bauer E, Feurle J, Weissinger F, Tony HP, Wilhelm M. Stimulation of γδ T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma. Blood 2000; 96:384-92.
24. Hudspeth K, Fogli M, Correia DV, Mikulak J, Roberto A, Della Bella S, Silva-Santos B, Mavilio D. Engagement of NKp30 on Vδ1 T cells induces the production of CCL3, CCL4, and CCL5 and suppresses HIV-1 replication. Blood 2012; 119:4013-6.
25. Takahashi H. Antigen presentation in vaccine development. Comp Immunol Microbiol Infect Dis 2003; 26:309-28.
26. Takahashi H. Species-specific CD1-restricted innate immunity for the development of HIV vaccine. Vaccine 2010; 28(Suppl. 2):B3-7.
27. Uldrich AP, Le Nours J, Pellicci DG et al. CD1d-lipid antigen recognition by the γδ TCR. Nat Immunol 2013; 14:1137-45.
28. + T cells. J Virol 2011; 85:1696-705.
29. Hinz T, Wesch D, Friese K, Reckziegel A, Arden B, Kabelitz D. T cell receptor γδ repertoire in HIV-1-infected individuals. Eur J Immunol 1994; 24:3044-9.
30. Cummings JS, Cairo C, Armstrong C, Davis CE, Pauza CD. Impacts of HIV infection on Vγ2Vδ2 T cell phenotype and function: a mechanism for reduced tumor immunity in AIDS. J Leukoc Biol 2008; 84:371-9.
31. + T cells expressing the natural cytotoxicity receptor NKp30 for recognition of lymphoid leukemia cells. Blood 2011; 118:992-1001.
32. Pang DJ, Neves JF, Sumaria N, Pennington DJ. Understanding the complexity of γδ T-cell subsets in mouse and human. Immunology 2012; 136:283-90.
33. + lymphocytes in AIDS and p24-antigenemic HIV-1-infected patients. Clin Immunol Immunopathol 1993; 69:248-50.
34. Poles MA, Barsoum S, Yu W et al. Human immunodeficiency virus type 1 induces persistent changes in mucosal and blood γδ T cells despite suppressive therapy. J Virol 2003; 77:10456-67.
35. Li H, Chaudry S, Poonia B, Shao Y, Pauza CD. Depletion and dysfunction of Vγ2Vδ2 T cells in HIV disease: mechanisms, impacts and therapeutic implications. Cell Mol Immunol 2013; 10:42-9.
36. Nilssen DE, Brandtzaeg P. Intraepithelial γδ T cells remain increased in the duodenum of AIDS patients despite antiretroviral treatment. PLoS ONE 2012; 7:e29066.
37. Poccia F, Battistini L, Cipriani B, Mancino G, Martini F, Gougeon ML, Colizzi V. Phosphoantigen-reactive Vγ9Vδ2 T lymphocytes suppress in vitro human immunodeficiency virus type 1 replication by cell-released antiviral factors including CC chemokines. J Infect Dis 1999; 180:858-61.